Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology


Gumusay O., Coskun U., AKMAN T., EKINCI A. S. , Kocar M., ERCELEB O. B. , et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, cilt.140, ss.151-157, 2014

  • Cilt numarası: 140 Konu: 1
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1007/s00432-013-1553-7
  • Dergi Adı: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • Sayfa Sayısı: ss.151-157

Özet

The development of brain metastases (BMs) was associated with poor prognosis in melanoma patients. Patients with BMs have a median survival of < 6 months. Melanoma is the third most common tumor to metastasize to the brain with a reported incidence of 10-40 %. Our aim was to identify factors predicting development of BMs and survival.